Cat of Nine Lives: A parent’s perspective on her son’s regression and treatment

Part Two of Ruth Morgan’s story

 

One of Jude’s Doctors joked that she’d ‘lost one of her cat lives‘ chasing IVIG (Intravenous Immunoglobulin) approval but luckily, she said, we have nine, don’t we?

It made me laugh but the more I thought about it, the more truth I saw tucked inside those words. Because what it took to get IVIG wasn’t just medicine. It was stamina. Determination. Passion and excellence. A relentless survival instinct from the people behind the scenes, fighting for him.

Before we even reached the first dose, there was the foundation of work, blood tests, neurological scoring, behavioural scales, clinical observations, and assessments to document what regression had taken. And the lumbar puncture under general anesthetic, the test no parent wants for their child, but one we had no choice but to do.

We needed to know the inflammation markers present and to rule out anything other than DSRD.

But the biggest battles were not only the ones we could see. Behind the scenes there was a team of brilliant advocates, all with a role in Jude’s hospital care, moving between boards, panels and committees. Each stage involved a specific internal process to approve a drug ‘off label’. The doctor had to clinically justify that IVIG was likely to work and was the only treatment available that could stop DSRD and give Jude his life back, and yet the decision rested with people who hadn’t even met him.

His doctor fought for him with absolute determination.

She had gathered her evidence and could see what Down’s Syndrome Regression Disorder had taken. Armed with data from a trial already underway in America, she hoped she could be the first doctor in the UK to deliver a miracle to a young boy that used to love his life.

The final hurdle, securing the drug itself, IVIG isn’t something you just ‘get’. It’s costly, tightly controlled, and has never been approved for DSRD in the UK. Despite the obvious clinical need and clear medical justification, the process of approval was complex and slow, shaped by layers of decision making and risk assessment.

After seven long months, IVIG was approved; we were given a nine-month plan, with the understanding that we would only continue if improvements were seen in the first three.

She said she lost a cat life in this process.

The truth is, she probably lost three. But’s its because of those ‘cat lives’ the ones the doctors spent so freely on him, that we finally reached the place where hope could begin.

A miracle was about to take place.


 

We’re very grateful to Ruth for sharing her story with us. You can read her first post here.

Click here for more information about ‘regression’ in Down’s syndrome.

You may also be interested in our online Regression Support Group for parents of those who’ve experienced a rapid regression.